Key statistics
Short selling activityProvided by S&P Global Market Intelligence
| Open | 20.18 |
|---|---|
| High | 20.18 |
| Low | 19.75 |
| Bid | 19.82 |
| Offer | 19.92 |
| Previous close | 19.75 |
| Average volume | -- |
|---|---|
| Shares outstanding | 166.65m |
| Free float | 163.58m |
| P/E (TTM) | 21.12 |
| Market cap | 5.04bn USD |
| EPS (TTM) | 1.43 USD |
Data delayed at least 15 minutes, as of Oct 30 2019.
More ▼
Press releases
- Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2025 and Provides Financial Expectations for 2026
- Alkermes plc Announces CEO Succession Plan
- Alkermes to Present at the TD Cowen 46th Annual Health Care Conference
- Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
- Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026
- Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1
- Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference
More ▼
